ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPK Opko Health Inc

1.27
0.05 (4.10%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,334,856
Bid Price 1.25
Ask Price 1.27
News -
Day High 1.28

Low
0.8516

52 Week Range

High
2.24

Day Low 1.22
Share Name Share Symbol Market Stock Type
Opko Health Inc OPK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 4.10% 1.27 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.25 1.22 1.28 1.27 1.22
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
8,000 5,334,856 US$ 1.24 US$ 6,628,842 - 0.8516 - 2.24
Last Trade Type Quantity Price Currency
18:58:57 formt 750 US$ 1.27 USD

Opko Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
885.18M 696.99M - 864.53M -188.86M -0.27 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Opko Health News

Date Time Source News Article
3/28/202407:00PR Newswire (US)Labcorp Announces Acquisition of Select Assets of..
3/20/202407:00GlobeNewswire Inc.Entera Bio Announces Robust Pharmacokinetic Data for..
3/07/202415:02Edgar (US Regulatory)Form ARS - Annual Report to Security Holders
3/05/202407:52GlobeNewswire Inc.AIDS Clinical Trial Group Presents Results from Phase 1..
3/01/202415:05Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form..
2/28/202408:31PR Newswire (US)NextPlat Opens OPKO Health-Branded Storefront on Alibaba's..
2/27/202415:07Edgar (US Regulatory)Form 8-K - Current report
2/27/202415:05GlobeNewswire Inc.OPKO Health Reports Fourth Quarter 2023 Business Highlights..
2/22/202415:05GlobeNewswire Inc.OPKO Health to Report Fourth Quarter 2023 Financial Results..
2/16/202415:53Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
2/09/202415:07Edgar (US Regulatory)Form 8-K - Current report
2/05/202407:09PR Newswire (US)NextPlat Receives Initial Approvals to Launch OPKO..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OPK Message Board. Create One! See More Posts on OPK Message Board See More Message Board Posts

Historical OPK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.261.311.191.234,007,4560.010.79%
1 Month1.331.431.191.295,520,663-0.06-4.51%
3 Months0.991.430.86011.078,800,2350.2828.28%
6 Months1.241.660.85161.049,308,8200.032.42%
1 Year1.482.240.85161.226,122,493-0.21-14.19%
3 Years4.135.250.85162.204,535,476-2.86-69.25%
5 Years2.386.470.85162.766,410,401-1.11-46.64%

Opko Health Description

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

Your Recent History

Delayed Upgrade Clock